Works matching U.S. Food and Drug Administration (FDA)

Results: 5000
    1
    2
    3

    Scientific and Regulatory Policy Committee Points to Consider: Review of the United States Food and Drug Administration (FDA) Guidance on Pathology Peer Review in Nonclinical Toxicology Studies.

    Published in:
    Toxicologic Pathology, 2024, v. 52, n. 2/3, p. 138, doi. 10.1177/01926233241248654
    By:
    • McDorman, Kevin S.;
    • Bennet, Bindu M.;
    • Colman, Karyn;
    • Fikes, James D.;
    • Keirstead, Natalie D.;
    • Lanning, Lynda;
    • Munch, Barbara;
    • Romeike, Annette;
    • Schafer, Kenneth A.;
    • Schorsch, Frédéric;
    • Thibodeau, Michael S.;
    • Thomas, Heath C.;
    • Troth, Sean;
    • Vahle, John L.;
    • Geoly, Frank J.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    American Epilepsy Society (AES): Written Comments to Norman E. "Ned" Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments : Submitted on: July 16, 2019

    Published in:
    Epilepsy Currents, 2019, v. 19, n. 6, p. 361, doi. 10.1177/1535759719878716
    By:
    • Welty, Timothy E.;
    • Chapman, Kevin E.;
    • Faught, R. Edward;
    • Kotloski, Robert J.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50